Apyx Medical Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -112.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -18.3% | +3.3% | -0.6% | -7.7% | -1.4% | -2.8% | -4.3% | +24.2% | +34.8% | -8.6% | -3.0% | – | |
| – | -32.3% | +23.4% | -6.9% | -5.0% | -15.9% | -46.2% | +15.3% | +1.9% | -5.7% | -37.6% | +344.2% | – | |
| – | -65.1% | -114.0% | – | -155.0% | – | – | -50.1% | -310.3% | – | – | -364.3% | – | |
| – | -46.6% | -62.4% | +725.7% | -47.1% | +60.1% | -77.6% | +381.8% | +95.8% | -47.0% | -78.2% | +10.0% | – | |
| – | -46.6% | -62.4% | +725.7% | -47.1% | +60.1% | -77.6% | +381.8% | +95.8% | -47.0% | -78.2% | +10.0% | – | |
| – | – | – | – | – | +0.0% | +0.0% | +0.0% | -20.0% | +50.0% | -16.7% | +0.0% | – | |
| – | +13,369.5% | -100.0% | +0.0% | +0.0% | – | -99.6% | +0.0% | +80.0% | +20,977.8% | -99.1% | -106.0% | – | |
| – | +488.7% | -129.6% | – | – | – | -119.6% | – | – | – | -109.1% | – | – | |
| – | -115.6% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.